Fund Tracker India by Ishaan Dungarwal
Guide
Fund similarityEquity Scheme - Mid Cap FundOct 2026

Axis Midcap Fund vs Nippon India Growth Mid Cap Fund: portfolio overlap

In Oct 2026, 46 stocks were in both portfolios, and the two overlap 41.4% by weight. A comparison, not advice.

Overlap41.4%by weight, Oct 2026
Stocks in common46held by both
Stocks held85 · 101Axis Midcap Fund · Nippon India Growth Mid Cap Fund

Axis Midcap Fund and Nippon India Growth Mid Cap Fund: stocks in common

% of each fund's net assets · Source: AMC monthly portfolio (SEBI disclosure), Oct 2026
StockAxis Midcap FundNippon India Growth Mid Cap Fund
FEDERALBNK The Federal Bank Limited4.27%2.85%
FORTIS Fortis Healthcare Limited2.62%2.67%
ETERNAL Eternal Limited2.23%2.67%
MCX Multi Commodity Exchange of India Limited2.14%3.20%
GVT&D GE Vernova T&D India Limited2.32%1.97%
BHARATFORG Bharat Forge Limited1.69%1.79%
INDHOTEL The Indian Hotels Company Limited2.67%1.48%
BHEL Bharat Heavy Electricals Limited1.70%1.35%
ALKEM Alkem Laboratories Limited1.37%1.29%
ICICIBANK ICICI Bank Limited1.83%1.27%
IPCALAB IPCA Laboratories Limited2.32%1.22%
NYKAA FSN E-Commerce Ventures Limited2.04%1.20%
AUBANK AU Small Finance Bank Limited1.19%2.49%
BSE BSE Limited1.18%2.73%
NAUKRI Info Edge (India) Limited1.10%2.55%
CUMMINSIND Cummins India Limited1.53%1.09%
ICICIGI ICICI Lombard General Insurance Company Limited1.04%2.10%
GLAND Gland Pharma Limited0.97%1.77%
DIXON Dixon Technologies (India) Limited1.32%0.94%
RADICO Radico Khaitan Limited1.68%0.91%
PAYTM One 97 Communications Limited0.89%2.37%
SUPREMEIND Supreme Industries Limited0.89%1.00%
TORNTPOWER Torrent Power Limited1.12%0.84%
CGPOWER CG Power and Industrial Solutions Limited0.78%0.84%
PAGEIND Page Industries Limited0.87%0.68%
SCHAEFFLER Schaeffler India Ltd.1.35%0.66%
MPHASIS Mphasis Ltd.0.78%0.61%
VMM Vishal Mega Mart Limited0.78%0.60%
SUNDARMFIN Sundaram Finance Limited0.59%0.78%
BLUESTARCO Blue Star Limited0.57%0.60%
MANKIND Mankind Pharma Limited0.48%1.99%
LGEINDIA LG Electronics India Ltd0.45%0.59%
COROMANDEL Coromandel International Limited0.94%0.42%
VOLTAS Voltas Limited0.41%1.49%
3MINDIA 3M India Limited0.49%0.36%
TRENT Trent Limited0.34%0.99%
ASTRAL Astral Limited0.32%0.55%
JKCEMENT JK Cement Limited1.05%0.30%
APARINDS Apar Industries Limited2.45%0.28%
INDIANB Indian Bank0.24%1.08%
M&MFIN Mahindra & Mahindra Financial Services Limited0.22%0.62%
INDIGO InterGlobe Aviation Limited1.09%0.19%
HINDPETRO Hindustan Petroleum Corporation Limited0.17%0.49%
SWIGGY Swiggy Limited0.16%0.87%
PIRAMALFIN Piramal Finance Ltd0.13%0.45%
RBLBANK RBL Bank Limited0.10%0.79%
How this is counted

Overlap = for every stock both hold, the smaller of its two weights, added up (as in the scheme finder's compare). Largest shared weight first.

Only in Axis Midcap Fund

largest 10 of 39 · Source: AMC monthly portfolio (SEBI disclosure), Oct 2026

Full portfolio on the scheme page →

Only in Nippon India Growth Mid Cap Fund

largest 10 of 55 · Source: AMC monthly portfolio (SEBI disclosure), Oct 2026

Full portfolio on the scheme page →

Side by side, as filed

FactAxis Midcap FundNippon India Growth Mid Cap Fund
Fund houseAxis Mutual FundNippon India Mutual Fund
AMFI categoryEquity Scheme - Mid Cap FundEquity Scheme - Mid Cap Fund
Equity held Oct 2026₹30,759 cr₹48,831 cr
Equity, % of fund Oct 202692.3%99.9%
Stocks held Oct 202685101
AUM average, July - September 2026₹34,576 cr₹51,142 cr
Total expense ratio, direct as of 13 Nov 20260.77 %0.76 %
Return 1 year 13 Nov 2025 to 13 Nov 2026+8.29 % in total+5.49 % in total
Return 3 years 13 Nov 2023 to 13 Nov 2026+17.19 % a year+16.97 % a year
Return 5 years 12 Nov 2021 to 13 Nov 2026+12.33 % a year+16.53 % a year
How this is counted

Category as AMFI lists it; AUM = AMFI's average AUM for the quarter; TER = the direct plan's total expense ratio on the date shown; returns = change in NAV between the two dates shown. Past performance may not be sustained in future.

Open these two in the scheme finder's compare →

Other overlap pages for these funds

Mutual fund investments are subject to market risks; read all scheme related documents carefully.